InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Wijngaard Peter. Director active across 1 company, notably Hepion Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €13k. History available since 15 September 2023. The latest transaction was disclosed on 24 November 2023 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条